Inventor
DENG XIANMING
CN31 patents
⚠️ This page may combine multiple inventors who share the name “DENG XIANMING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DANA FARBER CANCER INST INC
13 patentsUS9676792B2Jun 13, 2017
Pyrimido-diazepinone compounds and methods of treating disorders
DANA FARBER CANCER INST INC12 citations91
US9358231B2Jun 7, 2016
Type II RAF kinase inhibitors
DANA FARBER CANCER INST INC22 citations91
US9464091B2Oct 11, 2016
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
DANA FARBER CANCER INST INC5 citations84
US11826365B2Nov 28, 2023
Type II raf kinase inhibitors
DANA FARBER CANCER INST INC1 citations73
US10081639B2Sep 25, 2018
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
DANA FARBER CANCER INST INC2 citations73
US9701683B2Jul 11, 2017
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
DANA FARBER CANCER INST INC2 citations73
US10457692B2Oct 29, 2019
Pyrimido-diazepinone compounds and methods of treating disorders
DANA FARBER CANCER INST INC2 citations72
US10189861B2Jan 29, 2019
Pyrimido-diazepinone compounds and methods of treating disorders
DANA FARBER CANCER INST INC2 citations72
US11932646B2Mar 19, 2024
Small molecule myristate inhibitors of Bcr-abl and methods of use
DANA FARBER CANCER INST INC0 citations61
US11254682B2Feb 22, 2022
Small molecule myristate inhibitors of Bcr-abl and methods of use
DANA FARBER CANCER INST INC0 citations61
US10570154B2Feb 25, 2020
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
DANA FARBER CANCER INST INC0 citations52
US10787461B2Sep 29, 2020
Pyrimido-diazepinone compounds and methods of treating disorders
DANA FARBER CANCER INST INC0 citations51
US10787455B2Sep 29, 2020
Small molecule myristate inhibitors of BCR-ABL and methods of use
DANA FARBER CANCER INST INC0 citations50
UNIV XIAMEN
4 patentsUS11292787B2Apr 5, 2022
Five-membered-fused-six-membered aza-aromatic ring compound, preparation method thereof, pharmaceutical composition and application thereof
UNIV XIAMEN1 citations58
US11352354B2Jun 7, 2022
Substituted penta-fused hexa-heterocyclic compounds, preparation method therefor, drug combination and use thereof
UNIV XIAMEN1 citations57
US10508118B2Dec 17, 2019
Pyrimidopyrrole compounds, method for preparing the same, pharmaceutical compositions comprising the same and uses thereof
UNIV XIAMEN1 citations57
US11319322B2May 3, 2022
Substituted aryl ether compound, preparation method thereof, pharmaceutical composition and use thereof
UNIV XIAMEN0 citations43
GRAY NATHANAEL S
3 patentsUS9180127B2Nov 10, 2015
Type II Raf kinase inhibitors
GRAY NATHANAEL S24 citations89
US9266890B2Feb 23, 2016
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
GRAY NATHANAEL S7 citations78
US9670214B2Jun 6, 2017
Small molecule myristate inhibitors of Bcr-abl and methods of use
GRAY NATHANAEL S0 citations51
GRAY NATHANAEL
2 patentsUS GOV VETERANS AFFAIRS
2 patentsXIAMEN VIVOHEALTHS TECH CO LTD
2 patentsUS12410142B2Sep 9, 2025
Substituted imidazole salt compounds, preparation method thereof, pharmaceutical composition thereof and application thereof
XIAMEN VIVOHEALTHS TECH CO LTD0 citations48
US11584722B2Feb 21, 2023
Substituted imidazole salt compounds, preparation method thereof, pharmaceutical composition thereof and application thereof
XIAMEN VIVOHEALTHS TECH CO LTD1 citations48